Artelo Biosciences, Inc. (ARTL) | Solana Treasury Stock

Artelo Biosciences, Inc.
ARTL
$2.61 (2.35%)
Last update 07:59 PM UTC · Oct 23 · NASDAQ
#22 Solana Treasuries
Artelo Biosciences, Inc.
ARTL
#22 in Solana Treasuries
Solana Treasury Stock · NASDAQ · Solana Beach, US
$2.61 (2.35%)
Last update 07:59 PM UTC · Oct 23, 2026
SOL Holdings
1,525 SOL Treasury
Market Cap
$1.43M
Enterprise Value
-$2.92M

Market Overview

Market Cap
$1,429,690
Shares Outstanding
547,774
50-Day Moving Average
$4.72
200-Day Moving Average
$22.77
Average Volume (20 Days)
45,660
Beta (5Y)
-0.07

Price History

Date OPEN HIGH LOW CLOSE VWAP VOLUME %CHG $CHG

Artelo Biosciences, Inc. Company Overview

Artelo Biosciences, Inc. (NASDAQ: ARTL) is a clinical-stage biopharmaceutical company developing treatments that modulate the endocannabinoid system, with a pipeline including ART27.13 (Phase 1b/2a anorexia-associated-with-cancer), ART12.11 (cocrystal cannabidiol for inflammatory bowel disease and PTSD), and ART26.12 (a fatty-acid-binding-protein-5 inhibitor with peer-reviewed efficacy across visceral, inflammatory, neuropathic, and joint pain models). Artelo recently regained Nasdaq listing compliance and entered an AI-driven research collaboration with ScienceMachine to identify novel FABP5 inhibitor mechanisms. The company holds Solana on its balance sheet.

Artelo Biosciences, Inc. website url Visit Website Artelo Biosciences, Inc. linkedin url Artelo Biosciences, Inc. twitter url
Stock Exchange NASDAQ
IPO Date 2019-06-21
Number of Employees 7
Headquarters Solana Beach, California, US

Key Executives

Gregory D. Gorgas

President, CEO, Secretary,
Gregory D. Gorgas linkedin Gregory D. Gorgas twitter

Mark E. Spring

CFO and Treasurer
Mark E. Spring linkedin Mark E. Spring twitter

Featured Posts

View all articles

Press Releases

No press releases found.

SEC Filings

Form Type Filed Accepted Source

ARTL Frequently Asked Questions

The next earnings report date for Artelo Biosciences, Inc. (ARTL) is scheduled for November 17, 2026. Stay up to date with ’s financial results and key announcements by visiting our Earnings Tracker or by subscribing to earnings alerts. Here we also provide ARTL earnings call summaries and transcripts.

As of September 30, 2025, Artelo Biosciences, Inc. holds approximately 1,524.69 SOL . For more comprehensive insights, you can track ARTL 's Solana holdings on our Solana Treasuries page.

The current stock price of Artelo Biosciences, Inc. (ARTL) is $2.61 as of 07:59 PM UTC · Oct 23, 2026 . For live stock updates and company rankings, view our Bitcoin mining stocks by market cap table.

The latest news for Artelo Biosciences, Inc. (ARTL) includes Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform published on October 7, 2026 . For more details and ongoing updates, visit the ARTL news section.